Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis

Free Subscription Articles published in Vaccine Retrieve available abstracts of 84 articles: HTML format Text format

Single Articles

January 2010
1. LUO J , Li J, Chen RL, Nie L, et al
   Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers.
   Vaccine. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SOH SE , Ong DQ, Gerez I, Zhang X, et al
   Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination.
   Vaccine. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. PREGO C , Paolicelli P, Diaz B, Vicente S, et al
   Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
   Vaccine. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. FIRBAS C , Boehm T, Buerger V, Schuller E, et al
   Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine.
   Vaccine. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. BURGESS MA , McIntyre PB, Hellard M, Ruff TA, et al
   Antibody persistence six years after two doses of combined hepatitis A and B vaccine.
   Vaccine. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
6. KRISHNADAS DK , Li W, Kumar R, Tyrrell DL, et al
   HCV-core and NS3 antigens play disparate role in inducing regulatory or effector T cells in vivo: Implications for viral persistence or clearance.
   Vaccine. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ARYA SC , Agarwal N
   Re: Hepatitis A and E: Update on prevention and epidemiology.
   Vaccine. 2009.
   PubMed     Text format     Related articles   
   
   
   
8. CHAPKO MK , Yee HS, Monto A, Dominitz JA, et al
   Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
   Vaccine. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. POIRIER B , Variot P, Delourme P, Maurin J, et al
   Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?
   Vaccine. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. EL-AWADY MK , Tabll AA, Yousif H, El-Abd Y, et al
    Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. POTSCH DV , Oliveira ML, Ginuino C, Miguel JC, et al
    High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. PESSOA SD , Miyamoto M, Ono E, Gouvea AF, et al
    Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
13. ZHOU Q , Wang F, Yang F, Wang Y, et al
    Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ROTS NY , Wijmenga-Monsuur AJ, Luytjes W, Kaaijk P, et al
    Hepatitis B vaccination strategies tailored to different endemicity levels: Some considerations.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. JIRMO AC , Koya RC, Sundarassety BS, Pincha M, et al
    Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. FITZSIMONS D , Hendrickx G, Vorsters A, Van Damme P, et al
    Hepatitis A and E: Update on prevention and epidemiology.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. DUCLOS P
    Hepatitis B vaccines: WHO position paper-Recommendations.
    Vaccine. 2009.
    PubMed     Text format     Related articles   
    
    
    
18. YONG P , Voranush C, Apiradee T, Hans LB, et al
    Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
19. POOROLAJAL J , Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, et al
    Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. WIELAND A , Riedl P, Reimann J, Schirmbeck R, et al
    Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
21. BIAN G , Cheng Y, Wang Z, Hu Y, et al
    Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. WANG XJ , Gu K, Xiong QY, Shen L, et al
    A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. SHRIVASTAVA S , Lole KS, Tripathy AS, Shaligram US, et al
    Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. KIM MC , Kim MJ, Kwon YK, Lindberg AM, et al
    Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. HUNG HF , Chen TH
    Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
26. LIANG X , Bi S, Yang W, Wang L, et al
    Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. THARMAPHORNPILAS P , Rasdjarmrearnsook AO, Plianpanich S, Sa-Nguanmoo P, et al
    Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. LU JJ , Cheng CC, Chou SM, Hor CB, et al
    Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. GILCA V , De Serres G, Boulianne N, De Wals P, et al
    Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. LEONARDI S , Spina M, Spicuzza L, Rotolo N, et al
    Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies?
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. SHULER CM , Fiore AE, Neeman R, Bell BP, et al
    Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents-Benefit of universal infant hepatitis B vaccination.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. AFSAR B , Elsurer R, Eyileten T, Yilmaz MI, et al
    Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter?
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
33. MIQUILENA-COLINA ME , Lozano-Rodriguez T, Garcia-Pozo L, Saez A, et al
    Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LUNA EJ , Veras MA, Flannery B, de Moraes JC, et al
    Household survey of hepatitis B vaccine coverage among Brazilian children.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
35. WEDEMEYER H , Schuller E, Schlaphoff V, Stauber RE, et al
    Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. BRAUN LJ , Jezek J, Peterson S, Tyagi A, et al
    Characterization of a thermostable hepatitis B vaccine formulation.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. DANIELSSON N , Fakakovikaetau T, Szegedi E
    Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ASTURIAS EJ , Mayorga C, Caffaro C, Ramirez P, et al
    Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status.
    Vaccine. 2009;27:3650-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. VAN HOUDT R , Koedijk FD, Bruisten SM, Coul EL, et al
    Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: Does it work?
    Vaccine. 2009;27:3530-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
40. KALTENBOCK A , Dubischar-Kastner K, Eder G, Jilg W, et al
    Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX((R))1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. EGAN PM , Belfast MT, Gimenez JA, Sitrin RD, et al
    Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.
    Vaccine. 2009;27:3175-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. KLADE CS , Kubitschke A, Stauber RE, Meyer MF, et al
    Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.
    Vaccine. 2009;27:3099-108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. VORSTERS A , Van Herck K, Van Damme P
    The clock is running, ...
    Vaccine. 2009;27:2905-6.
    PubMed     Text format     Related articles   
    
    
    
44. LUQUERO FJ , Vallejo F, Fuente LD, Toro C, et al
    The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.
    Vaccine. 2009;27:2674-2679.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. LANDRUM ML , Hullsiek KH, Ganesan A, Weintrob AC, et al
    Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
46. ZUBKOVA I , Choi YH, Chang E, Pirollo K, et al
    T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.
    Vaccine. 2009;27:2594-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. GANCZAK M , Szych Z, Korzen M
    Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: A cross-sectional study.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. SAINI V , Sahoo MK, Murthy PK, Kohli D, et al
    Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine.
    Vaccine. 2009;27:2372-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
49. DENG Y , Zhang K, Tan W, Wang Y, et al
    A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice.
    Vaccine. 2009;27:2085-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HU Y , Zhou YH
    Concerns on Bacille Calmette-Guerin vaccination in infants born to mothers with hepatitis B virus infection.
    Vaccine. 2009;27:1987-8.
    PubMed     Text format     Related articles   
    
    
    February 2009
51. ROMANO L , Paladini S, Tagliacarne C, Zappa A, et al
    The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. RAPICETTA M , D'Ugo E, Argentini C, Catone S, et al
    New perspectives for hepatitis B vaccines and immunization.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. SANGARE L , Manhart L, Zehrung D, Wang CC, et al
    Intradermal hepatitis B vaccination: A systematic review and meta-analysis.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
54. KAO JT , Wang JH, Hung CH, Yen YH, et al
    Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ZHANG J , Liu CB, Li RC, Li YM, et al
    Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. LU PJ , Euler GL, Hennessey KA, Weinbaum CM, et al
    Hepatitis A vaccination coverage among adults aged 18-49 years in the United States.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. GRIFFITHS UK , Korczak VS, Ayalew D, Yigzaw A, et al
    Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. GIRAUDON I , Permalloo N, Nixon G, Charlett A, et al
    Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: A London study in 2006.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. HALPERIN SA , Tapiero B, Diaz-Mitoma F, Law BJ, et al
    Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Vaccine. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
60. KRETZSCHMAR M , Mangen MJ, van de Laar M, de Wit A, et al
    Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ARANKALLE VA , Lole KS, Deshmukh TM, Srivastava S, et al
    Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. HANSEN B , Belfast M, Soung G, Song L, et al
    Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
63. XIE Y , Sun HX, Li D
    Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. GREENGOLD B , Nyamathi A, Kominski G, Wiley D, et al
    Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. MONATH TP , Frey SE
    Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. GARNER-SPITZER E , Kundi M, Rendi-Wagner P, Winkler B, et al
    Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. CRUCIANI M , Mengoli C, Serpelloni G, Lanza A, et al
    Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
68. LIU FY , Guo RM, Zheng L, Lu YM, et al
    Safety evaluation of a canine hepatitis DNA vaccine.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. SIMANI OE , Leroux-Roels G, Francois G, Burnett RJ, et al
    Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. POLAT A , Akca H, Dagdeviren E
    Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. ZANETTI AR , Van Damme P, Shouval D
    The global impact of vaccination against hepatitis B: A historical overview.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
72. RENOUX V , Fleury MJ, Bousarghin L, Gaitan J, et al
    Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. BUT DY , Lai CL, Lim WL, Fung J, et al
    Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ARYA SC , Agarwal N, Gupta S
    Apropos "Hepatitis A in Jerusalem-The exception that proves the rule?"
    Vaccine. 2008.
    PubMed     Text format     Related articles   
    
    
    
75. HU Y , Wu Q, Xu B, Zhou Z, et al
    Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. OVIEDO M , Pilar Munoz M, Dominguez A, Borras E, et al
    A statistical model to estimate the impact of a hepatitis A vaccination programme.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. NYSTROM J , Cardell K, Bjornsdottir TB, Fryden A, et al
    Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. YIN Y , Zhang J, Dong D, Liu S, et al
    Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
79. FITZSIMONS DW
    Prevention and control of viral hepatitis: The role and impact of patient and advocacy groups in and outside Europe.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. REIN DB , Weinbaum CM
    The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. LANG KA , Yan J, Draghia-Akli R, Kahn A, et al
    Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus Macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. STEIN-ZAMIR C , Shoob H, Nubani N, Zentner G, et al
    Hepatitis a in Jerusalem-The exception that proves the rule?
    Vaccine. 2008.
    PubMed     Text format     Related articles   
    
    
    
83. LORENZO G , Martin-Folgar R, Rodriguez F, Brun A, et al
    Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
84. QIU Q , Wang RY, Jiao X, Jin B, et al
    Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.
    Vaccine. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: